Project DetailsProject Details

Deploying interdisciplinary medical teams to promote public health and disease control

Deploying interdisciplinary medical teams to promote public health and disease control

Keio doctors, nurses, pharmacists and other medical professionals will work together to provide high-quality medical care, expanding and developing our interdisciplinary approach to diagnosis. Preventive medicine is important in maintaining public health, and that is especially true for rapidly ageing societies like Japan’s. Since opening in August 2012, the Center for Preventive Medicine has played a pivotal role in developing Keio’s advanced comprehensive care by focusing on early detection and treatment.
Our interdisciplinary approach to diagnosis aims to do away with the traditional divisions between departments so that we can provide comprehensive treatments best suited to our patients’ needs. At the Cancer Center, where the interdisciplinary approach to diagnosis is already in operation, the five departments of outpatient chemotherapy, radiation therapy, palliative care, minimally invasive research, and rehabilitation work together to deliver advanced team medicine focused on patient quality of life. In 2011, the departments of internal medicine, dermatology, orthopedic surgery, and ophthalmology, among others, partnered to establish Keio’s Immunotherapy Center, the world's first specialized medical center to succeed in treating intractable immune disorders with biologics.
As we approach the School of Medicine’s centennial, we will continue developing our interdisciplinary cluster treatment system by expanding both our facilities and, in turn, the services we can provide. We are also taking a university-wide approach to anti-ageing medicine that will allow us to best meet the needs of our rapidly ageing society. Mental health is another area where we are focusing our efforts, and through collaboration between the Center for Stress Research and the business sector, we are working to make Keio Medicine available beyond the hospital. We recently established a Center for Perinatal & Pediatric Care by creating a new interdisciplinary cluster that brings together the departments of pediatrics, obstetrics and gynecology, and pediatric surgery. All of this, together with a new information system that will allow for the sharing of reservation and treatment information with healthcare partners and affiliated hospitals, is part of our plan to make Keio Medicine available to patients everywhere.

Establishing a global medical hub by developing the world's most advanced integration of basic and clinical medicine

Establishing a global medical hub by developing the world's most advanced integration of basic and clinical medicine

Since the Center for Integrated Medical Research opened in 2002, Keio has been at the forefront of stem cell and metabolomic research, and with the opening of the new hospital wing, we aim to lead the world in stem cell biology and metabolomic systems biology. The new hospital wing will house a cell-processing center which will conduct research into clinical applications of human iPS cells, both creating the foundation for a preventive medicine system, and promoting regenerative medicine to conquer serious illnesses such as neurodegenerative diseases, intractable immune disorders, chronic inflammatory diseases, and cancer.
Having reliable systems in place to translate the results of basic research into clinical practice is essential if basic and clinical medicine are to be truly integrated. We have established a translational research development system as well as a system for managing intellectual property and audits that will be instrumental in accelerating the production of new drugs and medical devices. These systems will benefit all of society by advancing regenerative medicine as well as preventive and personalized treatments based on genetic information. The Center for Medical Genetics, which opened in 2012, will be the focal point of a dynamic system that assembles medical staff into effective teams capable of making reliable diagnoses and providing unique, personalized treatments for patients with rare and incurable diseases. This new medical education and research center’s comprehensive procedures will enable it to efficiently process large volumes of imaging information from radiology and pathology so that appropriate treatment can be quickly provided. We are also pushing forward with imaging informatics research that utilizes advanced information technology to analyze vast amounts of medical-related data so that everything from new cancer diagnosis techniques to partnerships with healthcare centers across Japan and around the world can be strengthened.
In order to create the global hub that will allow us to achieve the above goals, the new hospital wing has been designed with world-leading health care accreditor JCI’s international safety standards in mind. Through these initiatives we plan to be a core hospital in the Asia-Pacific region.

Providing medical services in response to disasters in the metropolitan area

Shinanomachi Campus is home to Keio University School of Medicine and Keio University Hospital, which treats patients from all over the country. Located in the heart of Tokyo, adjacent to the expansive evacuation areas of Shinjuku Gyoen National Garden and Meiji Jingu Gaien, Keio University Hospital is required to provide medical care to nearby residents and evacuees in the event of a large-scale disaster.
Using lessons learned during the Great East Japan Earthquake in 2011, we are determined to make sure that the new hospital wing is not only earthquake-resistant, but is also able to respond to broader societal needs in times of distress. Keio is dedicated to making efficient use of the open spaces on Shinanomachi Campus that will be created by the construction of the new hospital wing to accommodate injured persons and refugees in times of disaster.
We understand that coordination and preparation are essential for effective disaster response, and we are promoting the establishment of a medical infrastructure in which the Tokyo Municipal Government, regional medical associations, and Sanshikai (Keio University School of Medicine’s alumni association) will cooperate to provide emergency care and subsequent physical and mental support in response to disasters.

Empowering tomorrow's leaders through robust inter-professional education programs

Empowering tomorrow's leaders through robust inter-professional education programs

Since 2011, Keio University has offered an inter-professional education (IPE) program which aims to improve cooperation and communication between students in the School of Medicine, the Faculty of Nursing and Medical Care, and the Faculty of Pharmacy. Our new comprehensive medical institution, with the new hospital wing at its core, will create an environment ideal for reinforcing students’ understanding and appreciation of the importance of team medicine. Keio always strives to provide an environment where the philosophy of hangaku hankyo (learning while teaching and teaching while learning) is a lifelong practice.
The School of Medicine has also launched an international medical alliance initiative with the objective of promoting social and medical contributions in developing countries and fostering a sense of cosmopolitanism in students by providing them with opportunities to train at medical institutions outside of Japan. The program aims to train world-leading doctors and researchers with a global perspective by further increasing and enhancing opportunities for graduate students and young researchers to study abroad.
Study-abroad programs, like the recently launched IPE research exchange program, also help strengthen solidarity between students from different faculties within Keio. Interdisciplinary development is, by definition, not something that the School of Medicine can provide by itself. By leveraging the whole Keio community to develop a culture of intellectual depth and compassionate understanding, we plan to address the problems that rapidly ageing societies face, particularly the legal and moral concerns surrounding the provision of cutting-edge treatment, including such issues as medical safety and economics, how humans will co-exist with science and technology, and anti-ageing practices.